Monoclonal Antibodies Partnering Deals and Agreements Entered by Leadi

Information about Monoclonal Antibodies Partnering Deals and Agreements Entered by Leadi

Published on August 6, 2014

Author: Jimmymarketbuzz

Source: authorstream.com

Content

Monoclonal Antibodies Partnering Terms and Agreements : Monoclonal Antibodies Partnering Terms and Agreements Published: June 2014 Single User PDF: US$ 2995 Corporate User PDF: US$ 14995 Order this report by calling +1 888 391 5441 or Send an email to [email protected] with your contact details and questions if any. 1 © ReportsnReports.com / Contact [email protected] Monoclonal Antibodies Partnering Terms and Agreements : Monoclonal Antibodies Partnering Terms and Agreements The  Monoclonal Antibodies Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the monoclonal antibodies partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter monoclonal antibody partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors monoclonal antibody technology. These deals tend to be multicomponent , starting with collaborative R&D, and commercialization of outcomes. This report provides details of the latest monoclonal antibody deals announced in the healthcare sectors. Buy a copy of report @ http://www.reportsnreports.com/Purchase.aspx?name=250370 . Order this report by calling +1 888 391 5441 or Send an email to [email protected] with your contact details and questions if any. 2 © ReportsnReports.com / Contact [email protected] Monoclonal Antibodies Partnering Terms and Agreements : Monoclonal Antibodies Partnering Terms and Agreements For example, analyzing actual company deals and agreements allows assessment of the following: What is actually granted by the agreement to the partner company? What exclusivity is granted? What are the precise rights granted or optioned? What is the payment structure for the deal? How aresalesand payments audited? What is the deal term? How are the key terms of the agreement defined? How are IPRs handled and owned? Who is responsible for commercialization? Who is responsible for development, supply, and manufacture? How is confidentiality and publication managed? How are disputes to be resolved? Under what conditions can the deal be terminated? Order this report by calling +1 888 391 5441 or Send an email to [email protected] with your contact details and questions if any. 3 © ReportsnReports.com / Contact [email protected] Monoclonal Antibodies Partnering Terms and Agreements : Monoclonal Antibodies Partnering Terms and Agreements What happens when there is a change of ownership? What sublicensing and subcontracting provisions have been agreed? Which boilerplate clauses does the company insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon for agreement law? The initial chapters of this report provide an orientation of monoclonal antibody dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in monoclonal antibody dealmaking since 2007, including details of average headline, upfront, milestone and royalty terms. Inquire for Discount @ http://www.reportsnreports.com/contacts/Discount.aspx?name=250370 . Order this report by calling +1 888 391 5441 or Send an email to [email protected] with your contact details and questions if any. 4 © ReportsnReports.com / Contact [email protected] Monoclonal Antibodies Partnering Terms and Agreements : Monoclonal Antibodies Partnering Terms and Agreements Report scope Monoclonal Antibodies Partnering Terms & Agreements is intended to provide the reader with an in-depth understanding and access to monoclonal antibodies trends and structure of deals entered into by leading companies worldwide. Monoclonal Antibodies Partnering Terms & Agreements includes: Trends in monoclonal antibodies dealmaking in the biopharma industry since 2007 Analysis of monoclonal antibodies deal structure Access to headline, upfront, milestone and royalty data Access to over 700 monoclonal antibodies deal records The leading monoclonal antibodies deals by value since 2007 Includes chimeric mAb , humanized mAb , human mAb and murine mAb deals and alliances since 2007 Order this report by calling +1 888 391 5441 or Send an email to [email protected] with your contact details and questions if any. 5 © ReportsnReports.com / Contact [email protected] Monoclonal Antibodies Partnering Terms and Agreements : Monoclonal Antibodies Partnering Terms and Agreements Monoclonal Antibodies Partnering Terms & Agreements provides the reader with the following key benefits: In-depth understanding of monoclonal antibodies deal trends since 2007 Access to headline, upfront, milestone and royalty data Acces to the structure of monoclonal antibodies agreements with numerous real life case studies Comprehensive access to over 700 actual monoclonal antibodies deals entered into by the world’s biopharma companies Insight into the terms included in a monoclonal antibodies agreement, together with real world clause examples Understand the key deal terms companies have agreed in previous deals          Undertake due diligence to assess suitability of your proposed deal terms for partner companies“ Order this report by calling +1 888 391 5441 or Send an email to [email protected] with your contact details and questions if any. 6 © ReportsnReports.com / Contact [email protected] Monoclonal Antibodies Partnering Terms and Agreements : Monoclonal Antibodies Partnering Terms and Agreements Explore Report on Pharmaceuticals Market . Contact  [email protected]  / Call +1 888 391 5441 for further information on “Monoclonal Antibodies Partnering Terms and Agreements” report OR for any other market research and intelligence needs you may have for your business. Order this report by calling +1 888 391 5441 or Send an email to [email protected] with your contact details and questions if any. 7 © ReportsnReports.com / Contact [email protected]

Related presentations


Other presentations created by Jimmymarketbuzz

Global Yellow Fever Industry
15. 05. 2014
0 views

Global Yellow Fever Industry

Australia Baby Food Market 2019
31. 07. 2014
0 views

Australia Baby Food Market 2019

US Housing Mortgage Market 2018
28. 10. 2014
0 views

US Housing Mortgage Market 2018

Global butter market 2015 2019
21. 07. 2015
0 views

Global butter market 2015 2019

Global tin market 2015 – 2019
14. 12. 2015
0 views

Global tin market 2015 – 2019